Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010 (2010), Article ID 137608, 7 pages
http://dx.doi.org/10.1155/2010/137608
Case Report

Promyelocytic Sarcoma of the Spine: A Case Report and Review of the Literature

1Hematology and BMT Unit, Institute of Hematotherapy, Ospedale S. Camillo, 00153 Rome, Italy
2Department of Biopathology, Tor Vergata University, 00133 Rome, Italy

Received 5 August 2009; Accepted 15 January 2010

Academic Editor: Stefan Faderl

Copyright © 2010 Leonardo Pacilli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Neiman, M. Barcos, C. Berard et al., “Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases,” Cancer, vol. 48, no. 6, pp. 1426–1437, 1981. View at Google Scholar · View at Scopus
  2. L. P. Menasce, S. S. Banerjee, E. Beckett, and M. Harris, “Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases,” Histopathology, vol. 34, no. 5, pp. 391–398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. P. H. Wiernik, R. De Bellis, P. Muxi, and J. P. Dutcher, “Extramedullary acute promyelocytic leukemia,” Cancer, vol. 78, p. 25, 1996. View at Google Scholar
  4. M. Benekli, M. C. Savas, I. C. Haznedaroglu, and S. V. Dündar, “Granulocytic sarcoma in acute promyelocytic leukemia,” Leukemia and Lymphoma, vol. 22, no. 1-2, pp. 183–185, 1996. View at Google Scholar · View at Scopus
  5. E. S. Jaffe, N. L. Harris, H. Stein, and J. W. Vardimann, Eds., World Health Organisation Classification of Tumours—Tumours of Haematopoietic and Lymphoid Tissues, vol. 105, IARC Press, London, UK, 2001.
  6. P. Fenaux, C. Chomienne, and L. Degos, “Acute promyelocytic leukemia: biology and treatment,” Seminars in Oncology, vol. 24, no. 1, pp. 92–102, 1997. View at Google Scholar · View at Scopus
  7. R. S. Larson and M. S. Tallman, “Retinoic acid syndrome: manifestations, pathogenesis, and treatment,” Best Practice and Research: Clinical Haematology, vol. 16, no. 3, pp. 453–461, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Estey, G. Garcia-Manero, A. Ferrajoli et al., “Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia,” Blood, vol. 107, no. 9, pp. 3469–3473, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. V. Liso, G. Specchia, E. M. Pogliani et al., “Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases,” Cancer, vol. 83, no. 8, pp. 1522–1528, 1998. View at Google Scholar
  10. A.-M. Tsimberidou, H. M. Kantarjian, E. Estey et al., “Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy,” Leukemia, vol. 17, no. 6, pp. 1100–1103, 2003. View at Publisher · View at Google Scholar · View at PubMed
  11. G. D. Evans and D. J. Grimwade, “Extramedullary disease is acute promyelocytic leukemia,” Leukemia and Lymphoma, vol. 33, no. 3-4, pp. 219–229, 1999. View at Google Scholar
  12. L. Degos, “All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia,” Biomedicine and Pharmacotherapy, vol. 46, no. 5–7, pp. 201–209, 1992. View at Google Scholar
  13. Y. Kanakura, T. Yonezawa, Y. Hamaguchi et al., “Acute promyelocytic leukemia with an intracerebral mass and meningeal involvement after treatment of non-Hodgkin's lymphoma,” Cancer, vol. 59, no. 1, pp. 94–98, 1987. View at Google Scholar · View at Scopus
  14. R. Marra, S. Stori, L. Pagano et al., “Central nervous system acute promyelocytic leukaemia: a report of three cases,” Haematologia, vol. 22, no. 3, pp. 195–199, 1989. View at Google Scholar · View at Scopus
  15. Z. Niazi, P. Molt, A. Mittelman, Z. A. Arlin, and T. Ahmed, “Leukemic dermal infiltrates at permanent indwelling central venous catheter insertion sites,” Cancer, vol. 68, no. 10, pp. 2281–2283, 1991. View at Google Scholar · View at Scopus
  16. M. R. Baer, M. Barcos, H. Farrell, A. Raza, and H. D. Preisler, “Acute myelogenous leukemia with leukemia cutis. eighteen cases seen between 1969 and 1986,” Cancer, vol. 63, no. 11, pp. 2192–2200, 1989. View at Google Scholar · View at Scopus
  17. T. A. Longacre and B. R. Smoller, “Leukemia cutis: analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes,” American Journal of Clinical Pathology, vol. 100, no. 3, pp. 276–284, 1993. View at Google Scholar · View at Scopus
  18. S. Giralt, S. O'Brien, E. Weeks, M. Luna, and H. Kantarjian, “Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid,” Leukemia and Lymphoma, vol. 14, no. 5-6, pp. 453–456, 1994. View at Google Scholar · View at Scopus
  19. G. Evans, D. Grimwade, H. G. Prentice, and N. Simpson, “Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid,” British Journal of Haematology, vol. 98, no. 2, pp. 437–439, 1997. View at Google Scholar · View at Scopus
  20. A. Menendez, A. Gonzales, H. Cabrera et al., “Clinical spectrum of extramedullary acute promyelocytic leukemia,” European Journal of Haematology, vol. 64, no. 3, pp. 201–203, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Byrd and R. B. Weiss, “Recurrent granulocytic sarcoma: an unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule,” Cancer, vol. 73, no. 8, pp. 2107–2112, 1994. View at Google Scholar · View at Scopus
  22. L. D. Burry and J. T. Seki, “CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid,” Annals of Pharmacotherapy, vol. 36, no. 12, pp. 1900–1906, 2002. View at Google Scholar · View at Scopus
  23. B.-S. Ko, J.-L. Tang, Y.-C. Chen et al., “Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia—the occurrence of retinoic acid syndrome is a risk factor,” Leukemia, vol. 13, no. 9, pp. 1406–1408, 1999. View at Google Scholar · View at Scopus
  24. K. Yamauchi and M. Yasuda, “Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature,” Cancer, vol. 94, no. 6, pp. 1739–1746, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. R. Mesa, E. Espinosa, R. Losada, C. Hernandez, G. Martinez, and P. Hernandez, “Parotid and central nervous system relapse during complete hematologic remission in acute promyelocytic leukemia,” Haematologica, vol. 84, no. 6, pp. 565–566, 1999. View at Google Scholar · View at Scopus
  26. M. Seldon and A. Enno, “Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid,” Australian and New Zealand Journal of Medicine, vol. 28, no. 4, p. 462, 1998. View at Google Scholar
  27. M. A. Weiss and R. P. Warrell Jr., “Two cases of extramedullary acute promyelocytic leukemia: cytogenetics, molecular biology, and phenotypic and clinical studies,” Cancer, vol. 74, no. 7, pp. 1882–1886, 1994. View at Google Scholar · View at Scopus
  28. G. Milone, G. Inghilterra, F. Li Gioi et al., “Testicular and cutaneous relapse after hematopoietic transplantation in a patient affected with APL,” Bone Marrow Transplantation, vol. 23, no. 7, p. 751, 1999. View at Google Scholar
  29. T. Kai, H. Kimura, Y. Shiga, K. Ogawa, H. Sato, and Y. Maruyama, “Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy,” International Journal of Hematology, vol. 83, no. 4, pp. 337–340, 2006. View at Publisher · View at Google Scholar · View at PubMed
  30. A. M. Tsimberidou, E. Estey, G. J. Whitman et al., “Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide,all-trans retinoic acid and gemtuzumab ozogamicin therapies,” Leukemia Research, vol. 28, pp. 991–994, 2004. View at Google Scholar
  31. S. Fukushima, M. Terasaki, Y. Tajima, and M. Shigemori, “Granulocytic sarcoma: an unusual complication of acute promyelocytic leukemia causing cerebellar hemorrhage. Case report,” Journal of Neurosurgery, vol. 105, no. 6, pp. 912–915, 2006. View at Publisher · View at Google Scholar · View at PubMed
  32. J. Worch, J. Ritter, and M. C. Frühwald, “Presentation of acute promyelocytic leukemia as granulocytic sarcoma,” Pediatric Blood and Cancer, vol. 50, no. 3, pp. 657–660, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. D. S. S. Ajarim, C. R. Santhosh-Kumar, K. E. Higgy, N. S. El Saghir, A. K. Al-Momen, and F. D. Shipkey, “Granulocytic sarcoma of the thymus in acute promyelocytic leukaemia,” Clinical and Laboratory Haematology, vol. 12, no. 1, pp. 97–99, 1990. View at Google Scholar
  34. A. Savranlar, Y. Ustündag, T. Ozer et al., “A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment,” Acta Medica Okayama, vol. 58, no. 5, pp. 251–254, 2004. View at Google Scholar
  35. D. M. Brown, A. E. Kimura, K. C. Ossoinig, and G. J. Weiner, “Acute promyelocytic infiltration of the optic nerve treated by oral trans-retinoic acid,” Ophthalmology, vol. 99, no. 9, pp. 1463–1467, 1992. View at Google Scholar
  36. N. Agarwal, E. M. Tepe, A. Mishra, and J. H. Ward, “Relapse of acute promyelocytic leukemia presenting as granulocytic sarcoma in the hip,” Annals of Hematology, vol. 85, no. 10, pp. 741–742, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. U. Disel, S. Yavuz, S. Paydas, B. Sahin, and H. Zeren, “Extramedullary relapse in the pleura in acute promyelocytic leukemia,” Leukemia and Lymphoma, vol. 44, no. 1, pp. 189–191, 2003. View at Publisher · View at Google Scholar
  38. G. Specchia, F. Lo Coco, M. Vignetti et al., “Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto,” Journal of Clinical Oncology, vol. 19, no. 20, pp. 4023–4028, 2001. View at Google Scholar
  39. R. Latagliata, I. Carmosino, M. Breccia et al., “Late relapses in acute promyelocytic leukaemia,” Acta Haematologica, vol. 117, no. 2, pp. 106–108, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. M. A. Sanz, L. Larrea, G. F. Sanz et al., “Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukaemia,” Haematologica, vol. 85, pp. 758–762, 2000. View at Google Scholar
  41. G. Magliulo, M. Fusconi, and G. Pulice, “Acute promyelocytic leukemia and aural recurrence: the importance of otoscopy in early diagnosis,” Leukemia, vol. 17, no. 7, pp. 1418–1419, 2003. View at Publisher · View at Google Scholar · View at PubMed
  42. B. Nasilowska-Adamska, M. Majewski, I. Seferynska et al., “Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT,” Annals of Transplantation, vol. 12, no. 3, pp. 33–38, 2007. View at Google Scholar
  43. V. Slavcheva, T. Lukanov, and N. Tzvetkov, “Two cases of extramedullary myeloid tumor in patients with continuous remission of acute myeloblastic leukemia,” Journal of BUON, vol. 13, no. 4, pp. 589–592, 2008. View at Google Scholar
  44. T. Kai, H. Kimura, Y. Shiga, K. Ogawa, H. Sato, and Y. Maruyama, “Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy,” International Journal of Hematology, vol. 83, no. 4, pp. 337–340, 2006. View at Publisher · View at Google Scholar · View at PubMed
  45. T. Tobita, K. Shinjyo, M. Yanagi, A. Takeshita, K. Ohnishi, and R. Ohno, “Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid,” Internal Medicine, vol. 36, no. 7, pp. 484–486, 1997. View at Google Scholar
  46. D. L. Forrest, B. I. Dalal, S. C. Naiman et al., “Testicular relapse of acute promyelocytic leukemia after allogeneic BMT,” Bone Marrow Transplantation, vol. 20, no. 8, pp. 689–690, 1997. View at Google Scholar
  47. A. Skarin, S. K. Ma, C. Ooi et al., “CNS extramedullary relapse of acute promyelocytic leukemia after arsenic trioxide—induced remission,” Journal of Clinical Oncology, vol. 18, pp. 3435–3437, 2000. View at Google Scholar
  48. F. Leoni, G. Gianfaldoni, M. Annunziata et al., “Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation,” Haematologica, vol. 87, no. 5, pp. 485–489, 2002. View at Google Scholar
  49. E. Ammatuna, P. A. Borza, A. P. Iori et al., “Multiple relapses and extramedullary localization with scalp and breast involvement in a case of acute promyelocytic leukemia,” Leukemia, vol. 19, no. 3, pp. 479–480, 2005. View at Publisher · View at Google Scholar · View at PubMed
  50. M. Breccia, M. C. Petti, A. M. Testi et al., “Ear involvement in acute promyelocytic leukemia at relapse: a disease associated ‘sanctuary’?” Leukemia, vol. 16, no. 6, pp. 1127–1130, 2002. View at Publisher · View at Google Scholar
  51. S. H. Bae, H. M. Ryoo, H. S. Cho, J. L. Lee, K. H. Lee, and M. S. Hyun, “Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature,” Journal of Korean Medical Science, vol. 19, no. 2, pp. 311–314, 2004. View at Google Scholar
  52. R. Ohno, N. Asou, and K. Ohnishi, “Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate,” Leukemia, vol. 17, no. 8, pp. 1454–1463, 2003. View at Publisher · View at Google Scholar · View at PubMed
  53. C. Samanez, S. Santillana, J. Leon, A. Wachtel, C. Vallejos, and Instituto de Enfermedades Neoplasicas, Lima, Peru, “Pattern of extramedullary relapse in acute promyelocytic leukemia (APL) in Peruvian patients,” in Proceedings of the Annual Meeting of American Society of Clinical Oncology (ASCO '02), vol. 21, 2002, abstract no. 1090.
  54. S. de Botton, M. A. Sanz, S. Chevret et al., “Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy,” Leukemia, vol. 20, no. 1, pp. 35–41, 2006. View at Publisher · View at Google Scholar · View at PubMed
  55. L. A. Casanova, S. M. Quintana, S. P. Neciosup, and C. A. Samanez, “Pattern of extramedullary relapse in latin patients with acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA) and chemotherapy,” in Proceedings of the Annual Meeting of American Society of Clinical Oncology (ASCO '07), vol. 25, p. 18S, 2007, abstract no. 1752.
  56. M. A. Sanz, D. Grimwade, M. S. Tallman et al., “Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet,” Blood, vol. 113, no. 9, pp. 1875–1891, 2009. View at Publisher · View at Google Scholar · View at PubMed
  57. F. Patriarca, C. Fili, A. Geromin, A. Sperotto, S. Prosdocimo, and R. Fanin, “Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia,” European Journal of Haematology, vol. 68, no. 5, pp. 310–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Esteve, L. Escoda, G. Martín et al., “Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention,” Leukemia, vol. 21, no. 3, pp. 446–452, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. E. H. Estey, “Treatment options for relapsed acute promyelocytic leukaemia,” Best Practice and Research: Clinical Haematology, vol. 16, no. 3, pp. 521–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Thomas, H. Dombret, C. Cordonnier et al., “Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation,” Leukemia, vol. 14, no. 6, pp. 1006–1013, 2000. View at Google Scholar · View at Scopus
  61. W. Y. Au, A. K. W. Lie, C. S. Chim et al., “Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia,” Annals of Oncology, vol. 14, no. 5, pp. 752–757, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Shigeno, K. Naito, N. Sahara et al., “Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies,” International Journal of Hematology, vol. 82, no. 3, pp. 224–229, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. M. S. Tallman, “Treatment of relapsed or refractory acute promyelocytic leukemia,” Best Practice and Research in Clinical Haematology, vol. 20, no. 1, pp. 57–65, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus